Showing results (1531-1540 of 2,025) with videos related to

Sort By:
Pageof 203
The Lancet. Global Health|August 28, 2019
The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort studySophie Uyoga, Alex W Macharia, George Mochamah, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2012
An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarolR M F van Schie, A M V Babajeff, T Schalekamp, et al.
Science Translational Medicine|July 20, 2022
Improving the diagnosis of severe malaria in African children using platelet counts and plasma PfHRP2 concentrationsJames A Watson, Sophie Uyoga, Perpetual Wanjiku, et al.
BMC Medicine|August 1, 2015
Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) ScoreElizabeth C George, A Sarah Walker, Sarah Kiguli, et al.
Applied and Environmental Microbiology|July 21, 2022
Regulation of l- and d-Aspartate Transport and Metabolism in Acinetobacter baylyi ADP1Stacy R Bedore, Alicia L Schmidt, Lauren E Slarks, et al.
Cancer Research|January 15, 2011
Use of macrophages to target therapeutic adenovirus to human prostate tumorsMunitta Muthana, Athina Giannoudis, Simon D Scott, et al.
The Annals of Thoracic Surgery|December 12, 2003
A multicenter comparison of intraaortic balloon pump utilization in isolated coronary artery bypass graft surgeryRoger J F Baskett, Gerald T O'Connor, Gregory M Hirsch, et al.
Cell Reports|October 19, 2022
Genomic landscape of drug response reveals mediators of anthelmintic resistanceStephen R Doyle, Roz Laing, David Bartley, et al.
Intensive Care Medicine|May 21, 2024
European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluidsYaseen M Arabi, Emilie Belley-Cote, Andrea Carsetti, et al.
Current Medical Research and Opinion|April 30, 2026
Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptomsDoris K Hansen, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, et al.
Pageof 203